MRNA Jan 2026 45.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 12:40PM EDT
Loading interactive chart…
- Investor's Business Daily
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
- Investor's Business Daily
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
- Investor's Business Daily
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.
© 2024 Yahoo. All rights reserved.